Designed Ankyrin Repeat Proteins as a tool box for analyzing p63

Alexander Strubel1, Philipp Münick1, Apirat Chaikuad2,3

  • 1Institute of Biophysical Chemistry and Center for Biomolecular Magnetic Resonance, Goethe University, 60438, Frankfurt, Germany.

Insights

Designed Ankyrin Repeat Proteins (DARPins) target p63 protein domains, enabling selective inhibition of transcription factors. This research reactivates p53 and reveals a negative feedback loop, offering a versatile tool for p63 research.

Area of Science:

  • Molecular Biology
  • Protein Engineering
  • Transcription Factor Regulation

Background:

  • The p53 transcription factor family, including p63 and p73, relies on specific folded domains for function.
  • Targeting transcription factors for inhibition is challenging due to the lack of suitable binding pockets for small molecules.
  • Investigating the roles of individual protein domains is difficult using traditional genetic methods.

Purpose of the Study:

  • To characterize Designed Ankyrin Repeat Proteins (DARPins) selected for binding to p63 folded domains.
  • To assess the potential of DARPins as intracellular inhibitors for modulating transcriptional activity.
  • To explore the utility of DARPins in studying p63 function and regulation.

Main Methods:

  • Selection and characterization of DARPins binding to p63 folded domains.
  • Determination of DARPin binding affinities and specificities within the p53 family.
  • In vitro and cellular assays to evaluate DARPin-mediated inhibition of transcriptional activity.

Main Results:

  • DARPins were identified as tight binders for all folded domains of p63.
  • DARPins effectively inhibited the DNA-binding activity of the ΔNp63α isoform, leading to p53 reactivation.
  • Inhibition of p63 DNA binding stabilized p63, indicating a negative feedback mechanism.
  • DARPins demonstrated binding to various p63 conformations and could detect p63 in biological samples.

Conclusions:

  • DARPins serve as potent intracellular inhibitors for p63, modulating transcriptional activity.
  • Selective inhibition of ΔNp63α by DARPins reactivates p53 and provides insights into regulatory feedback loops.
  • The developed DARPins are versatile tools for p63 research, including detection and functional studies.